Clinical Trial Update: Vitamin Replacement in Abetalipoproteinemia

View source ↗

Summary

The NHLBI-sponsored trial evaluating vitamin replacement therapy in individuals with abetalipoproteinemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abetalipoproteinemia

Drugs mentioned

• Multivitamin supplementation (multivitamin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Abetalipoproteinemia | Status: COMPLETED